Eltrombopag Tablet
Product Images NDC 0054-0964

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eltrombopag (NDC 0054-0964). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eltrombopag-chem-structure.jpg (Eltrombopag Chem Structure)

Chemical structure diagram of Eltrombopag Olamine showing its molecular framework with labeled functional groups and ring systems.*

FDA Label Image

12.5 mg Bottle Label (Eltrombopag 12 5mg Bl)

Eltrombopag Tablets 12.5 mg oral tablets label from Hikma Pharmaceuticals USA Inc. The label instructs to swallow tablets whole without splitting, chewing, or crushing and to dispense with the Medication Guide. It includes storage instructions and a warning about the printed safety seal under the cap. Each tablet contains eltrombopag olamine equivalent to 12.5 mg of eltrombopag free acid.*

FDA Label Image

25 mg Bottle Label (Eltrombopag 25mg Bl)

Eltrombopag 25 mg oral tablets label by Hikma Pharmaceuticals USA Inc. The label indicates 30 tablets, instructions to swallow whole without splitting, chewing, or crushing, and storage temperature guidelines. The packaging also notes safety seal warnings, dosage information reference, and manufacturer details including Zenara Pharma Private Limited.*

FDA Label Image

50 mg Bottle Label (Eltrombopag 50mg Bl)

Eltrombopag Tablets 50 mg oral tablet packaging label from Hikma Pharmaceuticals USA Inc. Contains 30 tablets with instructions to swallow whole, not to split, chew or crush. Storage is room temperature 20-25°C, dispensing in original bottle. Label includes warnings, dosage guidance to see prescribing information, and manufacturer details from Zenara Pharmaceuticals Pvt Ltd, India.*

FDA Label Image

75 mg Bottle Label (Eltrombopag 75mg Bl)

Eltrombopag Tablets 75 mg oral tablets, labeled for swallowing whole without splitting, chewing, or crushing. The label advises storage at room temperature and dispensing with a medication guide. The product is distributed by Hikma Pharmaceuticals USA Inc. and contains eltrombopag olamine equivalent to 75 mg eltrombopag free acid.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.